NEW YORK, Dec. 7, 2021 /PRNewswire/ -- The tissue microarray market share growth by the hospital segment will be significant for revenue generation. Tissue microarray is used for disease diagnosis in hospitals. In disease diagnosis applications, tissue microarrays have a high potential for analyzing more than thousands of tumor samples on a single slide. They also allow a high-throughput analysis of proteins and genes that can provide vital indications in cancer diagnosis. The global tissue microarray market is expected to grow by USD 3.14 billion from 2021 to 2206 at a CAGR of 7.75% as per the latest report by Technavio.
For more insights on the Tissue Microarray Market - View a FREE sample report in MINUTES
Read the 120-page report with TOC on "Tissue Microarray Market Analysis Report by End-user (hospitals, clinics, and diagnostics centers) and Geography (North America, Europe, Asia, and ROW), and the Segment Forecasts,2022-2026". Gain competitive intelligence about market leaders. Track key industry opportunities, trends and threats. Information on marketing, brand, strategy and market development, sales, and supply functions. https://www.technavio.com/report/report/tissue-microarray-market-industry-analysis
The tissue microarray market is driven by the growing number of cancer cases worldwide. However, factors such as the high cost of instruments and maintenance may impede the market growth. The holistic analysis of the drivers & challenges will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Some of key Tissue Microarray Players:
The tissue microarray market is concentrated and the vendors are deploying various organic and inorganic growth strategies to compete in the market.
Agilent Technologies Inc.
Bio Rad Laboratories Inc.
Bio Techne Corp.
Enzo Biochem Inc.
Molecular Devices LLC
OriGene Technologies Inc.
Thermo Fisher Scientific Inc.
Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Lite Plan" billed annually at USD 3000. View 3 reports monthly and Download 3 Reports Annually!
Tissue Microarray Market End-user Outlook (Revenue, USD bn, 2021-2026)
Hospitals - size and forecast 2021-2026
Clinics - size and forecast 2021-2026
Diagnostics centers - size and forecast 2021-2026
Tissue Microarray Market Geography Outlook (Revenue, USD bn, 2021-2026)
North America - size and forecast 2021-2026
Europe - size and forecast 2021-2026
Asia - size and forecast 2021-2026
ROW - size and forecast 2021-2026
For additional information on Segmentation -Grab an Exclusive Sample Report
In-vitro Diagnostics Market -The in-vitro diagnostics market share should rise by USD 35.77 billion from 2021 to 2025 at a CAGR of 7.95%. Download a free sample now!
Molecular Biology Enzymes, Kits, and Reagents Market -The molecular biology enzymes, kits, and reagents market share should rise by USD 13.09 billion from 2021 to 2025 at a CAGR of 14.61%. Download a free sample now!
Tissue Microarray Market Scope
Growth momentum & CAGR
Accelerate at a CAGR of 7.75%
Market growth 2022-2026
USD 3.14 billion
YoY growth (%)
North America, Europe, Asia, and ROW
Performing market contribution
North America at 36%
Key consumer countries
US, Canada, Germany, China, UK, Japan, France, India, and Mexico
Leading companies, competitive strategies, consumer engagement scope
Agilent Technologies Inc., Arrayit Corp., Bio Rad Laboratories Inc., Bio Techne Corp., Enzo Biochem Inc., Illumina Inc., Molecular Devices LLC, OriGene Technologies Inc., PerkinElmer Inc., and Thermo Fisher Scientific Inc.
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View original content to download multimedia:https://www.prnewswire.com/news-releases/tissue-microarray-market-to-grow-at-a-cagr-of-7-75-by-2026-hospitals-segment-to-be-significant-for-revenue-generation-17000-technavio-reports-301438237.html